Status:
UNKNOWN
Testing an Intervention in Irritative Contact Dermatitis
Lead Sponsor:
University of Split, School of Medicine
Conditions:
Contact Dermatitis
Contact Dermatitis Irritant
Eligibility:
All Genders
Phase:
NA
Brief Summary
An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, i...
Detailed Description
An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, i...
Eligibility Criteria
Inclusion
- healthy volunteers who gave written informed consent
Exclusion
- · skin cancer
- skin disease
- skin damage on measurement sites
- use of corticosteroids, antihistamines and immunomodulators a month prior the inclusion and during the trial
- use of drugs that may cause photosensitivity
- use of emollients three days prior the inclusion in the trial
- non-adherence to the trial protocol
- exposure to artificial and excessive natural ultraviolet (UV) radiation
- pregnancy and lactation
- history of vitiligo, melasma and other pigmentation and photosensitivity disorders
- immunosuppression
- allergic or irritant reactions to the constituents of the cream
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06189144
Start Date
June 1 2023
End Date
June 1 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Medicine
Split, Croatia, 21000